From 100PercentFedUp - READ ORIGINAL
Some media, including videos, may only be available to view at the original.
With the media fearmongering over avian influenza A (H5N1), it’s worth asking if public health officials and pharmaceutical companies already have an ‘approved’ vaccine.
We’ve seen reports of livestock infected with bird flu and a human case earlier this month.
“The Texas Department of State Health Services is reporting a human case of avian influenza A(H5N1) virus in Texas. The case was identified in a person who had direct exposure to dairy cattle presumed to be infected with avian influenza,” the Texas Department of State Health Services previously stated.
According to MedPage Today, “a trio of H5N1 vaccines for humans has already been developed and approved in the U.S.”
“A trio of H5N1 vaccines for humans has already been developed and approved in the U.S.” @COVIDSelect pic.twitter.com/68ahgLTcKi
— Mary Talley Bowden MD (@MdBreathe) April 23, 2024
A spokesperson for the Administration for Strategic Preparedness and Response (ASPR) told the outlet it is monitoring the situation closely with partners from the CDC, FDA, Department of Agriculture, and White House.
The spokesperson said the ASPR’s National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS) program “works closely with industry partners to make and test updated vaccines that match new strains of influenza viruses with pandemic potential as they emerge, while at the same time, supporting manufacturing capacity to allow for large-scale vaccine production if needed.”
“Hundreds of thousands of doses could be deployed within weeks pending regulatory action, and over 100 million doses could be deployed in the coming months,” the spokesperson told the outlet.
MedPage Today noted that three partners currently have H5N1 vaccines licensed for use in the United States – CSL Seqirus, GSK, and Sanofi.
“Why is the bird flu (highly pathogenic avian influenza, H5N1) human vaccine a US @NIH @BARDA project with CSL? Why is it called a ‘biodefense’ project?” Dr. Peter McCullough asked.
Why is the bird flu (highly pathogenic avian influenza, H5N1) human vaccine a US @NIH @BARDA project with CSL? Why is it called a “biodefense” project? Why is Community Notes writing deceiving messages on bird flu posts? All coming together now. https://t.co/shcLRGWkqL https://t.co/qIqju0ozgp pic.twitter.com/6ldTOQvLMU
— Peter A. McCullough, MD, MPH® (@P_McCulloughMD) April 23, 2024
* Image from Dr. Peter McCullough X Post *
Per MedPage Today:
Sanofi developed egg-based A/H5N1 vaccines as early as 2004 and received the first U.S. license for such a vaccine in 2007, a spokesperson for the company told MedPage Today.
“Our egg-based vaccine supply would well contribute to support a global influenza pandemic response should it arise either from A/H5N1 or any other influenza strain,” the spokesperson said, adding that in December 2019, Sanofi entered into an agreement with the Biomedical Advanced Research and Development Authority (BARDA) to “establish sustainable production of a recombinant vaccine for use in the event of a pandemic.”
That would allow the company “to leverage the technology used for one of our approved seasonal flu vaccines to deliver a pandemic vaccine,” the spokesperson said.
A spokesperson for GSK said the company is also monitoring the situation, along with the evolving epidemiology: “We are directly connected with our contractual partners to deliver on our commitments in the event that an influenza pandemic is declared.”
However, “GSK is not planning to disrupt seasonal flu production plans while there is no global health emergency,” the spokesperson added.
In 2022, the company was awarded multi-year contracts with the U.S., Canada, the European Union, and the WHO to supply its pandemic preparedness vaccine if the WHO declared an influenza pandemic, the spokesperson said. “These contracts will support the ready production and supply of this vaccine, and together could provide at least 200 million doses of pandemic influenza vaccine around the world.”
As for what may be currently available for use, the spokesperson said that the company’s pandemic vaccine is “developed to be updated with the latest circulating strains, and this follows the process for seasonal flu, where strains are identified by the WHO and vaccines are updated every season.”
“The timeline for this depends on several factors, including the licensing processes, which would be determined when a pandemic is declared,” the spokesperson noted.
For its part, CSL Seqirus said in a statement that it is able to “make a vaccine in response to government orders for use in a disease outbreak, for people who could be occupationally exposed to sick animals, or full-scale production of pandemic influenza vaccine should a pandemic be declared.”
“Fear Mongering, Food Supply Threat, Virus with a Deadly Past, BARDA Self-Amplifying mRNA Vaccines–A Perfect Storm is Brewing,” Dr. Peter McCullough previously stated.
“After warning us for months that 2024 could see another deadly pandemic, the medical establishment and governmental health organizations are sounding the alarm bells on bird flu. Not only are they drawing comparisons to COVID-19, they are in fact claiming that bird flu has the potential to be 100 TIMES MORE DEADLY!” 100 Percent Fed Up previously noted.
Read more HERE:
